Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
Nathan Ford1,2, Janice Lee1, Isabelle Andrieux-Meyer1, Alexandra Calmy1,31Médecins Sans Frontières, Geneva, Switzerland; 2Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa; 3Service of Infectious Diseases, Geneva U...
Guardado en:
Autores principales: | Ford N, Lee J, Andrieux-Meyer I, Calmy A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a784be7725104c80bb5ddfdbdbc6b295 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
por: Lee JSF, et al.
Publicado: (2012) -
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers E, et al.
Publicado: (2018) -
An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
por: Putcharoen O, et al.
Publicado: (2013) -
Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings
por: Scanlon ML, et al.
Publicado: (2013) -
Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir
por: Wainberg MA
Publicado: (2013)